Policy and Medicine Compliance Update August 2023 Issue Features: CMS Open Payments Reporting for 2023, Impact of Life Science Compliance, HHS-OIG revision of compliance guidance, and US Final Regulation for Drug Price Negotiations Read more
Policy and Medicine March 2022 Issue Features FDA Exclusivity, Baby Powder, and FCA Case Dismissal Read more
Vermont Disclosure Law: Samples Added to Reporting Requirements and Re-Instates Allowing Coffee for Conference Participants Read more
Participation of Academic Scientist in Relationships With Industry Shows Value in Relationship Read more